Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells.

Autor: Dvorakova T; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium.; Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium.; WEL Research Institute, Wavre, 1300, Belgium., Finisguerra V; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium.; Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium.; WEL Research Institute, Wavre, 1300, Belgium., Formenti M; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium.; Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium.; WEL Research Institute, Wavre, 1300, Belgium., Loriot A; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium., Boudhan L; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium.; Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium.; WEL Research Institute, Wavre, 1300, Belgium., Zhu J; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium. jingjng.zhu@uclouvain.be.; Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. jingjng.zhu@uclouvain.be.; WEL Research Institute, Wavre, 1300, Belgium. jingjng.zhu@uclouvain.be., Van den Eynde BJ; de Duve Institute, UCLouvain, Brussels, B-1200, Belgium. benoit.vandeneynde@uclouvain.be.; Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. benoit.vandeneynde@uclouvain.be.; WEL Research Institute, Wavre, 1300, Belgium. benoit.vandeneynde@uclouvain.be.; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford Oxford, Oxfordshire, UK. benoit.vandeneynde@uclouvain.be.

Publikováno v: Nature communications [Nat Commun] 2024 Sep 06; Vol. 15 (1), pp. 7789. Date of Electronic Publication: 2024 Sep 06.

Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.

Autor: Tapasztó B; Department of Ophthalmology, Semmelweis University, Budapest, Hungary.; Faculty of Health Sciences, Semmelweis University, Budapest, Hungary., Flitcroft DI; Temple Street Children's Hospital, Dublin, Ireland.; Centre for Eye Research Ireland (CERI) Technological University, Dublin, Ireland., Aclimandos WA; King's College Hospital, London, UK., Jonas JB; Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., De Faber JHN; Rotterdam Eye Hospital, Rotterdam, The Netherlands., Nagy ZZ; Department of Ophthalmology, Semmelweis University, Budapest, Hungary., Kestelyn PG; Department of Ophthalmology, Ghent University, Ghent, Belgium., Januleviciene I; Lithuanian University of Health Sciences, Kaunas, Lithuania., Grzybowski A; Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland., Vidinova CN; Department of Ophthalmology, Military Medical Academy, Sofia, Bulgaria.; Department of Optometry, Sofia University 'St. Kliment Ohridski', Sofia, Bulgaria., Guggenheim JA; School of Optometry & Vision Sciences, Cardiff University, Cardiff, UK., Polling JR; Department of Ophthalmology and Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Optometry and Orthoptics, University of Applied Science, Utrecht, The Netherlands., Wolffsohn JS; Optometry and Vision Science Research Group, College of Health and Life Sciences, Aston University, Birmingham, UK., Tideman JWL; Department of Ophthalmology and Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department Ophthalmology, Martini Hospital, Groningen, The Netherlands., Allen PM; Vision and Hearing Sciences Research Centre, Anglia Ruskin University, Cambridge, UK., Baraas RC; National Centre for Optics, Vision and Eye Care, University of South-Eastern Norway, Kongsberg, Norway., Saunders KJ; Centre for Optometry and Vision Science, Ulster University, Coleraine, UK., McCullough SJ; Centre for Optometry and Vision Science, Ulster University, Coleraine, UK., Gray LS; Glasgow Caledonian University, Glasgow, UK., Wahl S; Institute for Ophthalmic Research, University Tübingen, Tübingen, Germany.; Carl Zeiss Vision International GmbH, Tübingen, Germany., Smirnova IY; Siberian Center for the Prevention and Treatment of Myopia 'Glazka', Novosibirsk, Russia., Formenti M; Department of Physics, School of Science, University of Padova, Padova, Italy., Radhakrishnan H; Division of Pharmacy and Optometry, University of Manchester, Manchester, UK., Resnikoff S; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.; Brien Holden Vision Institute, Sydney, Australia., Németh J; Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Publikováno v: European journal of ophthalmology [Eur J Ophthalmol] 2024 Jul; Vol. 34 (4), pp. 952-966. Date of Electronic Publication: 2023 Dec 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.

Autor: Finisguerra V; de Duve Institute, UCLouvain, Brussels, Belgium benoit.vandeneynde@bru.licr.org veronica.finisguerra@uclouvain.be.; Ludwig Institute for Cancer Research, de Duve Institute, Brussels, Belgium.; Walloon Excellence in Life Science and Biotechnology (WELBIO), WEL Research Institute, Brussels, Belgium., Dvorakova T; de Duve Institute, UCLouvain, Brussels, Belgium.; Ludwig Institute for Cancer Research, de Duve Institute, Brussels, Belgium.; Walloon Excellence in Life Science and Biotechnology (WELBIO), WEL Research Institute, Brussels, Belgium., Formenti M; de Duve Institute, UCLouvain, Brussels, Belgium.; Ludwig Institute for Cancer Research, de Duve Institute, Brussels, Belgium.; Walloon Excellence in Life Science and Biotechnology (WELBIO), WEL Research Institute, Brussels, Belgium., Van Meerbeeck P; de Duve Institute, UCLouvain, Brussels, Belgium., Mignion L; Biomedical Magnetic Resonance (REMA) Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium.; Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium., Gallez B; Biomedical Magnetic Resonance (REMA) Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium.; Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium., Van den Eynde BJ; de Duve Institute, UCLouvain, Brussels, Belgium benoit.vandeneynde@bru.licr.org veronica.finisguerra@uclouvain.be.; Ludwig Institute for Cancer Research, de Duve Institute, Brussels, Belgium.; Walloon Excellence in Life Science and Biotechnology (WELBIO), WEL Research Institute, Brussels, Belgium.; Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 May; Vol. 11 (5).